Cumulus Neuroscience raises £6m in Dementia Discovery Fund-led financing round
Funds will be used to advance company’s integrated physiological and digital biomarker platform
Read More
Tag: Dementia Discovery Fund
DDF, Immuneering form $1.3m Alzheimer’s research collaboration
Britain’s Dementia Discovery Fund has formed a research collaboration with US group Immuneering Corporation that aims to identify novel drug targets and candidates for Alzheimer’s disease.
Read More
Gates streams $50m into Britain’s Dementia Discovery Fund
British venture the Dementia Discovery Fund (DDF) has received a $50 million investment from Bill Gates, to help fuel progress toward disease-modifying therapies for Alzheimer’s disease.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
